Search Results - Alessandra Ferrajoli

Refine Results
  1. 1
    An overview of prognostic markers in patients with CLL

    An overview of prognostic markers in patients with CLL by Julie Braish, Claudio Cerchione, Alessandra Ferrajoli

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Invasive fungal infections in acute leukemia

    Invasive fungal infections in acute leukemia by Vijaya Raj Bhatt, George M. Viola, Alessandra Ferrajoli

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review

    Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review by Francesco Autore, Paolo Strati, Luca Laurenti, Alessandra Ferrajoli

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    microRNA Therapeutics in Cancer — An Emerging Concept

    microRNA Therapeutics in Cancer — An Emerging Concept by Maitri Shah, Alessandra Ferrajoli, Anil K. Sood, Gabriel López-Berestein, George A. Călin

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia

    Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia by Elihu H. Estey, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Stefan Faderl, Srđan Verstovšek, Dan Jones, Hagop M. Kantarjian

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells

    STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells by Zhiming Liu, Inbal Hazan‐Halevy, David Harris, Ping Li, Alessandra Ferrajoli, Stefan Faderl, Michael J. Keating, Zeev Estrov

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia

    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia by Marco Montillo, Alessandra Tedeschi, Susan O’Brien, Francesco Di Raimondo, Susan Lerner, Alessandra Ferrajoli, Enrica Morra, Michael J. Keating

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors

    Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors by Z Estrov, Razelle Kurzrock, Elihu H. Estey, Meir Wetzler, Alessandra Ferrajoli, David Harris, Mary Blake, JU Gutterman, Moshe Talpaz

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia

    First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia by Yazan Numan, Mansour Alfayez, Abhishek Maiti, Yesid Alvarado, Elias Jabbour, Alessandra Ferrajoli, Sergej Konoplev, Hagop M. Kantarjian, Prithviraj Bose

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine

    Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine by Gautam Borthakur, Samih El Ahdab, Farhad Ravandi, Stefan Faderl, Alessandra Ferrajoli, Beth Newman, Jean–Pierre J. Issa, Hagop M. Kantarjian

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia

    Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia by Paolo Strati, William G. Wierda, Jan A. Burger, Alessandra Ferrajoli, Constantine S. Tam, Susan Lerner, Michael J. Keating, Susan O’Brien

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia

    Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute ly... by Elias Jabbour, Susan O’Brien, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Farhad Ravandi, Maria E. Cabanillas, Deborah A. Thomas

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells

    STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells by Inbal Hazan‐Halevy, David Harris, Zhiming Liu, Jie Liu, Ping Li, Xiaohong Chen, Sreejesh Shanker, Alessandra Ferrajoli, Michael J. Keating, Zeev Estrov

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion

    Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion by Paolo Strati, Michael J. Keating, Susan O’Brien, Alessandra Ferrajoli, Jan A. Burger, S. Faderl, Francesco Paolo Tambaro, Nitin Jain, William G. Wierda

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

    Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia by Lorenzo Falchi, Candida Vitale, Michael J. Keating, Susan Lerner, X. Wang, Kplola Y. Elhor Gbito, Sara S. Strom, William G. Wierda, Alessandra Ferrajoli

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome

    Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome by Jorge E. Cortés, Patricia Ault, Charles Koller, Deborah Thomas, Alessandra Ferrajoli, William G. Wierda, Mary Beth Rios, Laurie Letvak, Elizabeth S. Kaled, Hagop M. Kantarjian

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in‐situ</i> hybridization in 510 patients

    Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in‐situ</i> hybridization in 510 patien... by Constantine S. Tam, Joselle Otero‐Palacios, Lynne V. Abruzzo, Jeffrey L. Jorgensen, Alessandra Ferrajoli, William G. Wierda, Susan Lerner, Susan O’Brien, Michael J. Keating

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia by Xavier C. Badoux, Michael J. Keating, Sijin Wen, William G. Wierda, Susan O’Brien, Stefan Faderl, Rachel L. Sargent, Jan A. Burger, Alessandra Ferrajoli

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

    A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk m... by Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia‐Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srđan Verstovšek, Deborah A. Thomas, Monica Kwari, Hagop M. Kantarjian

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells

    WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells by Alessandra Ferrajoli, Stefan Faderl, Quin Van, Patricia E. Koch, David Harris, Zhiming Liu, Inbal Hazan‐Halevy, Yongtao Wang, Hagop M. Kantarjian, Waldemar Priebe, Zeev Estrov

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: